• Title/Summary/Keyword: Drug utilization

Search Result 222, Processing Time 0.026 seconds

폐 이식 후 신부전 발생 환자에서 유지 면역억제제로서 basiliximab의 사용 평가 (Medication Utilization Analysis of Basiliximab as a Maintenance Immunosuppressant in Renal Failure Patients Undergoing Lung Transplantation)

  • 서예진;금민정;이경아;김재송;손은선;유윤미
    • 한국임상약학회지
    • /
    • 제30권3호
    • /
    • pp.149-160
    • /
    • 2020
  • Background: Basiliximab is used as an alternative to tacrolimus in patients with decreased renal function. However, studies on basiliximab as a maintenance immunosuppressant, particularly in patients with lung transplantation, are limited. Therefore, here, we investigated the efficacy and safety of basiliximab in patients with lung transplantation. Methods: Adult patients with acute kidney injury (AKI) who received lung transplantation at a single general hospital between July 1, 2014 and June 30, 2018, were selected and classified in tacrolimus and basiliximab groups. Both groups received a triple-drug regimen (tacrolimus, mycophenolate mofetil, and steroids). However, tacrolimus was discontinued in the basiliximab group when AKI occurred, and two or more repeat basiliximab doses were administered within 3 months after transplantation. The electronic medical records were analyzed retrospectively. Results: Of the 85 patients who met the selection criteria, 61 and 24 were assigned to the tacrolimus and basiliximab groups, respectively. Significant improvement in renal function was observed in the basiliximab group (p <0.001). However, there were no differences in acute and chronic rejection rates in both the groups. No difference was observed in the incidence rate of complications between the groups, except for chronic kidney disease, which showed higher incidence in the basiliximab group (25.0% vs. 4.9%; p =0.013). Conclusions: We suggest the use of basiliximab as an immunosuppressant alternative to tacrolimus in patients with acute renal failure after lung transplantation. Basiliximab demonstrated effectiveness as an immunosuppressant and improved renal function. Therefore, basiliximab can be used in patients with decreased renal function.

The Flavin-Containing Reductase Domain of Cytochrome P450 BM3 Acts as a Surrogate for Mammalian NADPH-P450 Reductase

  • Park, Seon-Ha;Kang, Ji-Yeon;Kim, Dong-Hyun;Ahn, Taeho;Yun, Chul-Ho
    • Biomolecules & Therapeutics
    • /
    • 제20권6호
    • /
    • pp.562-568
    • /
    • 2012
  • Cytochrome P450 BM3 (CYP102A1) from Bacillus megaterium is a self-sufficient monooxygenase that consists of a heme domain and FAD/FMN-containing reductase domain (BMR). In this report, the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and 5-cyano-2,3-ditolyl tetrazolium chloride (CTC) by BMR was evaluated as a method for monitoring BMR activity. The electron transfer proceeds from NADPH to BMR and then to BMR substrates, MTT and CTC. MTT and CTC are monotetrazolium salts that form formazans upon reduction. The reduction of MTT and CTC followed classical Michaelis-Menten kinetics ($k_{cat}=4120\;min^{-1}$, $K_m=77{\mu}M$ for MTT and $k_{cat}=6580\;min^{-1}$, $K_m=51{\mu}M$ for CTC). Our continuous assay using MTT and CTC allows the simple, rapid measurement of BMR activity. The BMR was able to metabolize mitomycin C and doxorubicin, which are anticancer drug substrates for CPR, producing the same metabolites as those produced by CPR. Moreover, the BMR was able to interact with CYP1A2 and transfer electrons to promote the oxidation reactions of substrates by CYP1A2 and CYP2E1 in humans. The results of this study suggest the possibility of the utilization of BMR as a surrogate for mammalian CPR.

은행잎 제제의 급여제한 정책효과 분석 (Effects of reimbursement restriction on pharmaceutical expenditures : A case of Ginkgo biloba)

  • 권혜영;이태진
    • 보건행정학회지
    • /
    • 제21권2호
    • /
    • pp.249-262
    • /
    • 2011
  • Since May 1st in 2008, the products of ginkgo biloba extract have had to be used with the patient's out-of-pocket payment due to reimbursement restriction guidelines. This study aims to analyze the policy effects of reimbursement restriction on pharmaceutical expenditures using interrupted time series(ITS) analysis. We retrieved monthly NHI claims data for the period between May, 2005 and December 2009. The ingredients identified as a substitute for ginkgo biloba have similar indications based on the similar pharmacological activities. The effects of changes in reimbursement scope were evaluated both for all relevant pharmaceuticals within the same therapeutic class and for 2 separate groups : ginkgo biloba's and its substitutes. According to the study results, restrictions on reimbursement scope resulted in savings of the drug expenditures in the targeted therapeutic class. Direct restriction on ginkgo biloba was associated with a decrease in expenditure level by 60.1% and changes in trend from an average increase rate of 1.4% to an average decrease rate of 1.5% for the therapeutic class, with a dramatic decrease in expenditure level(-191.5%) for ginkgo biloba itself, but with an increased expenditure level(+50.1%) and changes in trend from an average increase rate of 2.0% to an average decrease rate of 1.0% for the substitute group. Further policy to restrict nicergoline was associated with additional decrease in expenditure level for the therapeutic class. Additionally, we could identify the balloon effect - a new policy squeezing one part results in bulging out elsewhere. After the restriction of ginkgo biloba, the utilization of and expenditures on its substitutes increased significantly. In conclusion, we demonstrated that consecutively introduced policies effectively reduced overall expenditures on the therapeutic class of interest. Some ingredients played as a substitute while others did not. Further studies need to be conducted to identify which factors determine a substitute.

Immune-enhancing effect of Acanthopanax Koreanum and its component, Eleutheroside E on the protein-energy malnourished C57bl/6 mice

  • Kim, Na-Hyung;Kim, Kyu-Yeob;Kim, Jeong-Ah;Kim, Young-Ho;Kang, In-Cheol;Kim, Hyung-Min;Jeong, Hyun-Ja
    • Advances in Traditional Medicine
    • /
    • 제10권3호
    • /
    • pp.191-199
    • /
    • 2010
  • Acanthopanax Koreanum stem (AK) has been used in Korea as a tonic and sedative as well as a drug with ginseng like activities. The purpose of our present study was to investigate the effects of AK extract (AKE) and Eleutheroside E, major component of AKE on an exacerbated immune function through utilization of protein-energy malnutrition (PEM) diet by using forced swimming test (FST). The immobility time were significantly decreased in the AKE or Eleutheroside E-administrated group compared with the control group on the FST (P < 0.05). The level of blood parameters were not changed significantly. PEM-induced weight loss of mice was reduced by oral administration of 500 mg/kg AKE. AKE oral administration improved the nutritional status such as the food efficiency ratio and the adrenal gland weight. AKE treatment significantly increased the production of interferon (IFN)-$\gamma$ compared with unstimulated splenocytes but not interleukin (IL)-4. Eleutheroside E also significantly increased the IFN-$\gamma$ production but not IL-2 and IL-4 in T cell line, MOLT-4 cells. These results suggest that AKE and Eleutheroside E may influence to immune-enhancing through increasing the physical endurance capacity and immune cell activation.

병원 의사결정지원시스템의 서비스 품질이 경영성과에 미치는 영향 : K대병원 사례 중심으로 (A Study on the Effects of the Service Quality of Hospital's Decision Support System on Management Performance : the Case of K-University Hospital)

  • 박진희;권두순;이미영
    • Journal of Information Technology Applications and Management
    • /
    • 제21권2호
    • /
    • pp.81-98
    • /
    • 2014
  • Recently, due to external environment like the changes in health policy and various healthcare accreditations, along with hospital's internal efforts to improve the quality of medical services, demands for the development of medical information systems are increasing. Some examples are clinical information like DUR (Drug Utilization Review), CVR (Critical Value Report), and automatic benefit processing by treatment purposes, or hospital DSS (Decision Support System) on overall medical practice. Such systems act as a guide in making clinic judgments during practice or in other medical practice, and their effects on the medical treatment improvements are being proven by previous studies. In the reality of increasing attention in the effects of medical treatment improvement, studies related to hospital DDS were mostly focused on clinical, technical, and engineering points of view, and studies focusing on the user viewpoint are very limited. In order to verify the effects of DSS on practice improvements and hospital's management performance, this study used a research model constructed to verify how SERVQUAL of hospital DSS affects hospital management performance in BSC (Balanced Score Card) point of view. To empirically verify the research model, a questionnaire was conducted on the basis of "K-University Hospital's DSS" on clinicians and hospital employees related to system development, and the relationships between the factors were analyzed through path analysis. As a result of path analysis, excluding reactivity, tangibility, confidence, reliability, empathy among service qualities, had partially significant effects on management performance factors (learning and growth, internal process, financial affairs). This study is to prepare the theoretical ground on the management performance analysis of hospital DSS, and suggest the service quality of the system that should be considered in the planning and development stages for improved system.

주요 건강기능식품 관련 홍보용 인터넷 건강 정보에 대한 평가 (Evaluation of Promotional Internet Health Information about Health Functional Foods)

  • 최지영;이진석
    • 보건교육건강증진학회지
    • /
    • 제31권2호
    • /
    • pp.65-78
    • /
    • 2014
  • Objectives: The aim of this study is to evaluate promotional Internet health information on health functional foods with regard to labeling information, website structure, and overall quality. Methods : The websites of 15 producers of three health functional foods (Red ginseng, vitamin, aloe) were selected. Ministry of Food and Drug Safety (MFDS) required labeling information was used to evaluate the integrity of basic information, and the structural properties of the websites were investigated. Moreover, DISCERN instrument was used to evaluate reliability and quality of information. Results : 1) Among MFDS required labeling information, seven items, including 'sell by date', and 'possible side effects' were not fully specified, and only 6.7% of Internet advertisements provided 'possible side effects'. 2) Each of 92.9% of these websites offered 'Introducation to websites and producers', and 'customer service', whereas only 64.3% and 42.9% of these websites offered 'FAQ about website utilization' and 'multilingual support', respectively. 3) The evaluation using DISCERN instrument showed the scores of $2.03{\pm}0.24$ in reliability, $1.87{\pm}0.28$ in quality, and $2.10{\pm}0.55$ in overall quality. Conclusions : Current promotional Internet health information on health functional foods has various weaknesses in terms of reliability and quality that need to be improved.

대규모 과학응용을 위한 효율적인 분산 슈퍼컴퓨팅 자원관리 기술 연구 (Effective Distributed Supercomputing Resource Management for Large Scale Scientific Applications)

  • 노승우;김직수;김상완;김서영;황순욱
    • 정보과학회 논문지
    • /
    • 제42권5호
    • /
    • pp.573-579
    • /
    • 2015
  • 국가 슈퍼컴퓨팅 인프라는 국내 여러 지역에 분산된 슈퍼컴퓨팅 클러스터들로 이루어져 있으며, 본 연구팀에서는 이러한 이기종의 지리적으로 분산된 클러스터들을 대규모 과학 응용 연구자들에게 효율적으로 제공하기 위해 대규모 계산처리 시스템인 HTCaaS(High-Throughput Computing as a Service)를 자체 개발하였다. 본 논문에서는 이러한 대규모 계산처리 시스템(HTCaaS)을 활용하여 각 계산 자원을 동적으로 관리하는 방법에 대해서 논의하고, 신약재창출이라는 실제 과학 응용을 통해 그 효율성을 검증한다. 특히 유효 자원 식별을 위한 대기시간 및 성공률 개념을 이용한 동적 계산 자원 관리 기술을 적용함으로써 자원 활용률과 정확성, 신뢰성, 편의성이 향상될 수 있으며, 그 결과 전체적인 작업 시간의 단축과 작업 처리량도 향상될 수 있음을 확인할 수 있었다.

HMDI 가교 폴리아스팔트아미드 수화젤의 제조 및 특성 (Preparation and Properties of Biodegradable Hydrogels from Poly(2-hydroxyethyl aspartamide) and HMDI)

  • 김정훈;심상준;이동현;김덕준;이영관;김지홍
    • 폴리머
    • /
    • 제29권5호
    • /
    • pp.518-521
    • /
    • 2005
  • 생분해성 고분자와 수화젤의 약물 전달 시스템과 조직 공학을 포함하는 다양한 생의학적인 응용이 점차 확대되고 있다. 하이드록실 pendant group을 갖고 있는 폴리아미노산의 하나인 PHEA는 뛰어난 생분해성과 우수한 생체적합성을 갖는 고분자로 알려져 있다 PHEA 및 그 유도고분자를 제조하고 이를 다양한 생의학적인 응용에 적용하는 연구가 진행되어 왔다. 본 연구에서는 유기용매에서 가교제인 HMDI를 사용하여 PHEA 수화젤을 제조하였다. PHEA는 아스팔트산의 열 축중합에 의해 합성한 polysuccinimide와 ethanolamine과의 고분자 반응으로부터 제조하였다. 제조한 수화젤에 대한 서로 다른 수용액과 pH용액에서의 팽윤 거동을 조사하였고, SEM을 통한 수화젤의 모폴로지와 가수분해 거동을 관찰하였다.

일부 다빈도 상병에서 입원진료비의 변이 정도와 요인에 대한 연구 (Inpatient Cost Variation among Hospitals in Some Tracer Diseases)

  • 김윤;김용익;신영수
    • 보건행정학회지
    • /
    • 제3권1호
    • /
    • pp.25-52
    • /
    • 1993
  • Variation in the utilization of medical services is a very important issue in cost containment and quality assurance of health care. Practice variation directly affects health care expenditure especially in fee-for-service system, which is the payment system of health insurance in Korea. In addition to cost issue it is generally accepted that variations in medical practice and the cost of inpatient care suggest the possibility of inappropriate quality of care. This study is to closely examine the patterne and degrees of variation in cost structure of inpatient care among types of hospital and individual hospitals in some tracer diseases, and also to inquire into the service items which contribute much to the variation of total medical care cost. Foru common diseases, i.e. Cesarean Section, appendectomy, cataract extraction and pediatric pneumonia, were selected as tracer diseases. In most tracer diseases there were statistically significant differences in total medical care cost among hospitals in same type of hospital as well as among types of hospital(p<0.01). When total medical care cost were subdivided into the types of service, cost of medication and diagnostic examination varied the most prominenly. When the cost of medication were subdivided again, cost of parenteral antibiotics showed the most prominent variation. Of total medical care cost, medication was most contributory to the variation of total medical care cost(58.1~82.3%), and cost of antibiotics was most contributory to the variation of medication cost(63.9~92.2%). The results of study implicated that reducing the variation of medication may plays a significant role in containing the cost of inpatient care. In order to sort out the factors affecting practice variations including drug prescription pattes further researches are required.

  • PDF

「승정원일기」에 기록된 녹두죽 활용에 대한 고찰 (Study on Use of Mung Bean Porridge Reported in Daily Records of Royal Secretariat of Joseon Dynasty)

  • 박주영;이향영;이진철;안상우
    • 한국식생활문화학회지
    • /
    • 제31권6호
    • /
    • pp.541-553
    • /
    • 2016
  • Medicinal porridge (藥粥) is made by putting rice or grains into a pot and boiling with water until a semi-liquid texture is obtained. Porridge is digested fast and absorbed by the body. Children or elderly people with weak digestive ability can eat it without difficulty. The authors of this literature focused on utilization of mung bean porridge (Nokdu-juk) based on SeungjeongwonIlgi (承政院日記), which is the daily record of the Royal Secretariat of the Joseon Dynasty from 1623 to 1910. Four cases were found. The first case used mungbean for treating fever diseases (熱症), the second as a meal alternative, the third for wound recovery, and the last case described the culture of the joseon dynasty. According to the actual cases in SeungjeongwonIlgi (承政院日記), mung bean porridge (Nokdu-juk) was actively used to lower fever and strengthen the spleen and stomach. When suffering from the after effects of a malignant tumor or serious liver disease (肝病), an infectious disease, or a serious physical wound, people ate mung bean porridge (Nokdu-juk). It is suggested that mung bean porridge (Nokdu-juk) can be used as an alternative food treatment for the current medical field due to the prevalence of pain-killers and psychotropic drug abuse.